Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -251,576 | -128,081 | -79,000 | -142,110 | -170,447 |
| Depreciation Amortization | 30,952 | 26,178 | 18,650 | 5,477 | 5,463 |
| Income taxes - deferred | 8,829 | N/A | 199 | -199 | N/A |
| Accounts receivable | 11,525 | -29,589 | -12,203 | -14,842 | -6,907 |
| Other Working Capital | 20,427 | 14,209 | 13,228 | -8,963 | 4,699 |
| Other Operating Activity | 81,204 | 89,642 | 49,063 | 57,071 | 42,855 |
| Operating Cash Flow | $-98,639 | $-27,641 | $-10,063 | $-103,566 | $-124,337 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -337,798 | 21,809 | 93,381 | 106,257 | -18,091 |
| PPE Investments | -13,757 | -7,097 | -3,101 | -1,776 | -2,720 |
| Net Acquisitions | N/A | -48,892 | N/A | N/A | N/A |
| Purchase Of Investment | -4,000 | 0 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -31,682 | -8,433 | -77,163 | N/A | N/A |
| Other Investing Activity | -31,682 | -8,433 | -77,163 | 0 | 0 |
| Investing Cash Flow | $-387,237 | $-42,613 | $13,117 | $104,481 | $-20,811 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 279,267 | 0 | 40,000 | N/A | 150,000 |
| Debt Repayment | -11,667 | 0 | 0 | N/A | N/A |
| Common Stock Issued | 345,609 | 131,571 | 4,650 | 968 | 8,711 |
| Other Financing Activity | 0 | 0 | -432 | 0 | -4,650 |
| Financing Cash Flow | $613,209 | $131,571 | $44,218 | $968 | $154,061 |
| Exchange Rate Effect | -1,303 | -3,611 | 6,199 | -1,584 | -639 |
| Beginning Cash Position | 169,498 | 111,792 | 58,321 | 58,022 | 49,748 |
| End Cash Position | 295,528 | 169,498 | 111,792 | 58,321 | 58,022 |
| Net Cash Flow | $126,030 | $57,706 | $53,471 | $299 | $8,274 |
| Free Cash Flow | |||||
| Operating Cash Flow | -98,639 | -27,641 | -10,063 | -103,566 | -124,337 |
| Capital Expenditure | -13,757 | -7,097 | -3,101 | -1,776 | -2,720 |
| Free Cash Flow | -112,396 | -34,738 | -13,164 | -105,342 | -127,057 |